NuVasive Gains 510(k) for Modulus Cervical Interbody with Bone Void Filler

NuVasive Modulus Cervical Interbody

NuVasive received FDA 510(k) clearance for the use of its Modulus Cervical interbody implant with a bone void filler, thus enhancing the company's C360 portfolio.

Attrax Putty is reportedly the first synthetic bone graft substitute to receive FDA-cleared Indications for Use in thoracolumbar interbody fusion spacers. Subsequently published...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us